Skip to main content

Peer Review reports

From: Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

Original Submission
24 Nov 2011 Submitted Original manuscript
28 Nov 2011 Author responded Author comments - Charlotte Huijts
Resubmission - Version 2
28 Nov 2011 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
30 Nov 2011 Author responded Author comments - Charlotte Huijts
Resubmission - Version 4
30 Nov 2011 Submitted Manuscript version 4
Publishing
30 Nov 2011 Editorially accepted
30 Nov 2011 Article published 10.1186/1471-2407-11-505

You can find further information about peer review here.

Back to article page